Skip to search formSkip to main contentSkip to account menu

HIV Envelope Protein gp120

Known as: HTLV III gp120, gp120, Envelope Glycoprotein gp120, HIV 
External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains… 
National Institutes of Health

Related topics

Related topics

24 relations

Narrower (9)

B1M-P3C protein, recombinantCLIV peptideKAB 121MNrgp120 vaccine
CD4 AntigensGenes, ViralIn BloodPeptide T

Broader (1)

HIV envelope protein

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neurons
Human immunodeficiency virus (HIV)–associated sensory neuropathy (HIV‐SN) is the most common neurological complication of HIV… 
Highly Cited
1998
Highly Cited
1998
Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins
ABSTRACT Whole inactivated viral particles have been successfully used as vaccines for some viruses, but procedures historically… 
Highly Cited
1998
Highly Cited
1998
Three‐dimensional solution structure of the 44 kDa ectodomain of SIV gp41
The solution structure of the ectodomain of simian immunodeficiency virus (SIV) gp41 (e‐gp41), consisting of residues 27–149, has… 
Highly Cited
1996
Highly Cited
1996
HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.
The Ab-dependent cell-mediated cytotoxicity (ADCC) activity of anti-gp120 Abs in serum from four groups of HIV-1-positive… 
Highly Cited
1990
Highly Cited
1990
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.
The principal neutralizing determinant (PND) of human immunodeficiency virus HIV-1 is part of a disulfide bridged loop in the… 
Highly Cited
1989
Highly Cited
1989
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
The principal neutralizing determinant of human immunodeficiency virus type 1 (HIV-1) is located in the external envelope protein… 
Highly Cited
1989
Highly Cited
1989
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus
In vitro infection by the human immunodeficiency virus (HIV) of CD4+ H9 lymphoblasts is inhibited by a mannose-binding protein… 
Highly Cited
1989
Highly Cited
1989
Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.
Cell fusion (syncytium formation) is a major cytopathic effect of infection by human immunodeficiency virus (HIV) and may also… 
Highly Cited
1988
Highly Cited
1988
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope
A monoclonal antibody was produced to the exterior envelope glycoprotein (gp120) of the human T-cell lymphotropic virus (HTLV… 
Highly Cited
1986
Highly Cited
1986
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.
Immunization with either an Escherichia coli recombinant segment of the human T-cell lymphotropic virus (HTLV-III/LAV) envelope… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)